Helping Patients with COPD Breathe Easier
The goal of the educational program is to help practitioners
assess the comparative effectiveness and safety of medications used to manage
the symptoms of COPD; understand the evidence regarding appropriate therapy;
weigh the benefits, risks, and value of treatment options; and improve the
quality of prescribing and patient care. In addition to providing this evidence
document, the education program uses an innovative approach: academic
detailing, which involves one-on-one educational sessions in physicians'
offices with trained outreach educators who present the educational material
interactively. Reference cards for clinicians and education materials for
family members are also provided.
reading this material, a participant will be familiar with:
spirometry data and clinical symptoms to diagnose and follow COPD patients
according to the GOLD 4-stage classification system.
- For patients who
smoke, begin by assessing their willingness to quit, and then tailor
recommendations appropriate for their stage of readiness.
- Prescribe a
regimen of exercise, good nutrition, and immunizations at all stages of
- Match drug therapy to disease severity according to the new
GOLD 4-stage system.
- Prescribe oxygen for patients with chronic
- Treat acute exacerbations aggressively with short-acting
bronchodilators, systemic steroids and antibiotics where appropriate.
Michael Fischer, M.D., M.S. is an Associate Professor
of Medicine at Harvard Medical School and a primary care internist who studies
cost-effective drug use in outpatient practices.
Jerry Avorn, M.D. is a
Professor of Medicine at Harvard Medical School and Chief of the Division of
Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital. An
internist, he has worked as a primary care physician and geriatrician and has
been studying drug use and its outcomes for over 30 years.
Choudhry, M.D., Ph.D. is a Professor of Medicine at Harvard Medical School and
a hospitalist at Brigham and Women's Hospital. His research focuses on the use
of medications to treat common chronic conditions.
Michael H. Cho,
M.D., M.P.H. is an Assistant Professor in the Division of Pulmonary and
Critical Care Medicine and the Division of Network Medicine at Brigham and
Women's Hospital Medicine and Harvard Medical School.
PharmD, M.P.H., is the Director of Clinical Materials Development at Alosa
Stephen Braun, B.A. is a medical writer based in Amherst, MA.
Carolyn E. Come, M.D., M.P.H. is an Instructor in Medicine at
Harvard Medical School and a pulmonary and critical care physician at Brigham
and Women's Hospital. Her primary research interests are exploring the
association between COPD and cardiovascular disease and the impact of lung
volume reduction on cardiopulmonary physiology.
Massachusetts Medical Society (MMS) Member: $30.00
Allied Health Professionals: $24.00
Format: Text &
Text & Graphics
This activity has been
planned and implemented in accordance with the accreditation requirements and
policies of the Accreditation Council for Continuing Medical Education (ACCME)
through the joint providership of the Massachusetts Medical Society and Alosa
Health, Inc. The Massachusetts Medical Society is accredited by the
Accreditation Council for Continuing Medical Education to provide continuing
medical education for physicians.
AMA Credit Designation
The Massachusetts Medical Society designates this enduring
material for a maximum of 2.5 AMA PRA Category 1 Credit™.
Physicians should claim only credit commensurate with the extent of their
participation in the activity.
Participants will receive a confidential
report of their examination score. A score of 70% or higher is required to
receive AMA PRA Category 1 Credit™
Start: February 28, 2017
End: February 28, 2018
Windows, XP, Vista, 7, 8
Mac OSX 10.6 higher
Most modern browsers including:
Flash player is required for some Online CME courses.
iOS devices beginning with OS version 5 or higher
(includes, iPhone, ipad and iTouch devices)
Android devices including
tablets and phones.
Windows RT and tablets on Windows 8 are also